Overview
Carbohydrate-based drug design is a rapidly growing area of drug discovery and development. It involves the use of carbohydrates as drug targets, either alone or in combination with other molecules, to create new therapeutic agents capable of modulating biological processes. The most common carbohydrate-based drugs are glycosylated proteins and peptides, as well as small molecule and oligosaccharide-based drugs. These drugs can be used to treat a variety of diseases, including inflammation, cancer, and infectious diseases. Carbohydrate-based drug design has great potential to significantly improve current therapeutic strategies and to develop new treatments and strategies for disease management.
Research published in this journal
No peer-reviewed research on this exact topic has been published in Carbohydrates yet. Browse the journal →